Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts

Neurology

Volumn 46, Issue 5, 1996, Pages 1219-1225

  Folkerth, Rebecca D ^a,c   Durso, Raymon ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CYCLOSPORIN; HOMOVANILLIC ACID; PREDNISONE;

ADULT; ALLOGRAFT; ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN VENTRICLE; CASE REPORT; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FETAL TISSUE TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NERVE TRANSPLANTATION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0029895301     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.5.1219     Document Type: Article

References (63)

1. Backlund E-O, Granberg P-O, Hamberger B, et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. J Neurosurg 1985;62:169-173.
2. Lindvall O, Backlund E-O, Frade L, et al. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol 1987;22:457-468.
3. Madrazo I, Drucker-Colín R, Díaz V, Martínez-Mata J, Torres C, Becerril JJ. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's Disease. N Engl J Med 1987;316:831-834.
4. Goetz CG, Olanow W, Koller WC, et al. Multicenter study of autologous adenal medulla transplantation to the corpus striatum in patients with advanced Parkinson's Disease. N Engl J Med 1989;320:337-342.
5. Kelly PJ, Ahlskog JE, van Heerden JA, Carmichael SW, Stoddard SL, Bell GN. Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. Mayo Clin Proc 1989;64:282-290.
6. Apuzzo MLJ, Neal JH, Waters CH, et al. Utilization of unilateral and bilateral sterotactically placed adrenomedullary-striatal autografts in Parkinsonian humans: rationale, techniques, and observations. Neurosurgery 1990;26:746-757.
7. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247:574-577.
8. Spencer DD, Robbins RJ, Naftolin F, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992;327:1541-1548.
9. Freed CR, Breeze RE, Rosenberg NL, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992;327:1549-1555.
10. Widner H, Tetrud J, Rehncrona S, et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP). N Engl J Med 1992;327:1556-1563.
11. Sawle GV, Bloomfield PM, Bjorklund A, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F] 6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol 1992;31:166-173.
12. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994;35:172-180.
13. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
14. Rosenfeld JV, Kilpatrick TJ, Bartlett PF. Neural transplantation for Parkinson's disease: a critical appraisal. Aust N Z J Med 1991;21:477-484.
15. Bakay RA. Neurotransplantation: a clinical update. Acta Neurochir Suppl (Wien) 1993;58:8-16.
16. Goetz CG, Stebbins GT III, Klawans HL, et al. United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up. Prog Brain Res 1990;82:611-617.
17. Quinn NP. The clinical application of cell grafting techniques in patients with Parkinson's disease. Prog Brain Res 1990;82: 619-625.
18. Turner DA, Kearney W. Scientific and ethical concerns in neural fetal tissue transplantation. Neurosurgery 1993;33: 1031-1037.
19. Council on Scientific Affairs and Council on Ethical and Judicial Affairs. Medical applications of fetal tissue transplantation. JAMA 1990;263:565-570.
20. Kassirer JP, Angell M. The use of fetal tissue in research on Parkinson's disease. N Engl J Med 1992;327:1591-1592.
21. Carry DJ, Caplan AL, Vawter DE, Kearney W. Sounding Board. Are there really alternatives to the use of fetal tissue from elective abortions in transplantation research? N Engl J Med 1992;327:1592-1595.
22. Morihisa JM, Nakamura RK, Freed WJ, Mishkin M, Wyatt RJ. Adrenal medulla grafts survive and exhibit catecholamine-specific fluorescence in the primate brain. Exp Neurol 1984;84:643-653.
23. Dunnett SB. Towards a neural transplantation therapy for Parkinson's disease: experimental principles from animal studies. Acta Neurochir Suppl (Wien) 1991;52:35-38.
24. Ahlskog JE. Cerebral transplantation for Parkinson's disease: current progress and future prospects. Mayo Clin Proc 1993; 68:578-591.
25. Landau WM. Clinical neuromythology X. Faithful fashion: survival status of the brain transplant cure for parkinsonism. Neurology 1993;43:644-649.
26. Feiten DL. Cell transplantation and research design. Science 1994;263:1546.
27. Redmond DE Jr, Roth RH, Elsworth JD, et al. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1986;1:1125-1127.
28. Sladek JR, Gash DM. Nerve-cell grafting in Parkinson's disease. J Neurosurg 1988;68:337-351.
29. Bankiewicz KS, Plunkett RJ, Jacobowitcz DM, et al. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. J Neurosurg 1990;72:231-244.
30. Bankiewicz KS, Plunkett RJ, Jacobowitz DM, Kopin IJ, Oldfield EH. Fetal nondopaminergic neural implants in parkinsonian primates. J Neurosurg 1991;74:97-104.
31. Annett LE, Martel FL, Roger DC, Ridley RM, Baker HF, Dunnett SB. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the migrostriatal pathway. Exp Neurol 1994;125:228-246.
32. Peterson DI, Price ML, Small CS. Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology 1989;39:235-238.
33. Hurtig H, Joyce J, Sladek JR, Trojanowski JQ. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol 1989;25:607-614.
34. Jankovic J. Adrenal medullary autografts in patients with Parkinson's disease [letter]. N Engl J Med 1989;321:325-326.
35. Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw J-J, Agid YA. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease. Ann Neurol 1990;27:676-682.
36. Redmond DE Jr, Leranth C, Spencer DD, et al. Fetal neural graft survival. Lancet 1990;336:820-822.
37. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New Engl J Med 1995;332:1118-1124.
38. Iacono RP, Tang ZS, Mazziotta JC, Grafton S, Hoehn M. Bilateral fetal grafts for Parkinson's disease: 22 months' results. Sterotact Funct Neurosurg 1992;58:84-87.
39. Szabo GK, Davoudi H, Durso R. High-performance liquid Chromatographie method for measuring homovanillic acid in cerebrospinal fluid using electrochemical detection with internal standardization. J Chromatogr 1988;430:112-117.
40. Sladek JR, Gash DM. Neural transplantation for Parkinson's disease. J Neurosurg 1988;69:807-810.
41. Freed WJ, Dymecki J, Poltorak M, Rodgers CR. Intraventricular brain allografts and xenografts: studies of survival and rejection with and without systemic sensitization. Prog Brain Res 1988;78:233-241.
42. Nishino H, Ono T, Takahashi J, Kiniura M, Shiosaka S, Tohyama M. Transplants in the periand intraventricular region grow better than those in the central parenchyma of the caudate. Neurosci Lett 1986;64:184-190.
43. Pear BL. Iatrogenic intraspinal epidermoid sequestration cysts. Radiology 1969;92:251-254.
44. Rosenstein JM, Brightman MW. Intact cerebral ventricle as a site of tissue transplantation. Nature 1978;276:83-85.
45. Baetge EE. Neural stem cells for CNS transplantation. Ann NY Acad Sci 1993;695:285-291.
46. Rosenfeld JV, Bartlett PF, Kerr RSC. Tissue grafting and immunosuppression [letter]. J Neurosurg 1991;74:157-158.
47. Widner H, Brundin P. Immunological aspects of grafting in the mammalian central nervous system: a review and speculative synthesis. Brain Res Brain Res Rev 1988;13:287-324.
48. Broadwell RD, Baker BJ, Ebert PS, Hickey WF. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations. Microsc Res Tech 1994;27:471-494.
49. Lawrence JM, Morris RJ, Wilson DJ, Raisman G. Mechanisms of allograft rejection in the rat brain. Neuroscience 1990;37:431-462.
50. Date I, Kawamura K, Nakashima H. Histological signs of immune reactions against allogeneic solid fetal neural grafts in the mouse cerebellum depend on the MHC locus. Exp Brain Res 1988;73:15-22.
51. Lund RD, Rao K, Kunz HW, Gill TJ III. Immunological considerations in neural transplantation. Transplant Proc 1989; 21:3159-3162.
52. Brundin P, Nilsson OG, Gage FH, Bjorklund A. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res 1985;60: 204-208.
53. Bankiewicz K, Plunkett RJ, Oldfield EH. Tissue grafting and immunosuppression [letter]. J Neurosurg 1991;74:158-159.
54. Fahn S. Fetal-tissue transplantations in Parkinson's disease. N Engl J Med 1992;327:1589-1590.
55. Widner H, Brundin P, Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected? Cell Transplant 1993;2:307-317.
56. Duan WM, Widner H, Bjorklund A, Brundin P. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Neuroscience 1993;57:261-274.
57. Hoffer BJ, Leenders KL, Young D, et al. Eighteen-months course of two patients with grafts of fetal dopamine neurons for severe Parkinson's disease. Exp Neurol 1992;118:242-252.
58. Sawle GV, Myers R. The role of positron emission tomography in the assessment of human neurotransplantation. Trends Neurosci 1993;16:172-176.
59. Hansen JT, Kordower JH, Fiandaca MS, Jiao S-S, Notter MFD, Gash DM. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: graft viability and fine structure. Exp Neurol 1988;102:65-75.
60. Fiandaca MS, Kordower JH, Hansen JT, Jiao S-S, Gash DM. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp Neurol 1988;102: 76-91.
61. Giullian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985;228:497-499.
62. Sheng JG, McShane LM, Plunkett RJ, et al. Dopaminergic neuronal sprouting and behavioral recovery in hemiparkinsonian rats after implantation of amnion cells. Exp Neurol 1993; 123:192-203.
63. Hoffer BJ, van Home C. Survival of dopaminergic neurons in fetal-tissue grafts. New Engl J Med 1995;332:1163-1164.